Expeditors International of Washington, Inc. (NASDAQ:EXPD – Get Free Report) has earned a consensus rating of “Reduce” from the eleven ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $115.33.
EXPD has been the topic of several recent research reports. Wolfe Research downgraded Expeditors International of Washington from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 9th. Bank of America raised their target price on Expeditors International of Washington from $131.00 to $132.00 and gave the company a “neutral” rating in a research report on Monday, July 22nd. UBS Group upgraded Expeditors International of Washington from a “sell” rating to a “neutral” rating and raised their target price for the company from $95.00 to $137.00 in a research report on Thursday, August 1st. TD Cowen cut Expeditors International of Washington from a “hold” rating to a “sell” rating and lowered their target price for the company from $112.00 to $106.00 in a research report on Monday, October 14th. Finally, Benchmark reiterated a “hold” rating on shares of Expeditors International of Washington in a research report on Wednesday, August 7th.
Check Out Our Latest Stock Analysis on EXPD
Expeditors International of Washington Stock Up 1.1 %
Expeditors International of Washington (NASDAQ:EXPD – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The transportation company reported $1.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.26 by ($0.02). The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.28 billion. Expeditors International of Washington had a return on equity of 29.15% and a net margin of 7.40%. The company’s revenue for the quarter was up 8.9% on a year-over-year basis. During the same period last year, the business posted $1.30 EPS. As a group, sell-side analysts expect that Expeditors International of Washington will post 5.04 EPS for the current fiscal year.
Hedge Funds Weigh In On Expeditors International of Washington
A number of hedge funds have recently modified their holdings of EXPD. Hara Capital LLC acquired a new stake in shares of Expeditors International of Washington in the third quarter worth $26,000. Crewe Advisors LLC acquired a new stake in shares of Expeditors International of Washington in the first quarter worth $25,000. Innealta Capital LLC acquired a new stake in shares of Expeditors International of Washington in the second quarter worth $31,000. Family Firm Inc. acquired a new stake in shares of Expeditors International of Washington in the second quarter worth $35,000. Finally, Ashton Thomas Private Wealth LLC acquired a new stake in shares of Expeditors International of Washington in the second quarter worth $52,000. 94.02% of the stock is currently owned by institutional investors and hedge funds.
About Expeditors International of Washington
Expeditors International of Washington, Inc, together with its subsidiaries, provides logistics services worldwide. The company offers airfreight services, such as air freight consolidation and forwarding; ocean freight and ocean services, including ocean freight consolidation, direct ocean forwarding, and order management; customs brokerage, import, intra-continental ground transportation and delivery, and warehousing and distribution services; and customs clearance, purchase order management, vendor consolidation, time-definite transportation services, temperature-controlled transit, cargo insurance, specialized cargo monitoring and tracking, and other supply chain solutions.
See Also
- Five stocks we like better than Expeditors International of Washington
- Investing in Commodities: What Are They? How to Invest in Them
- Intel: Is Now the Time to Be Brave?Â
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Upcoming IPO Stock Lockup Period, Explained
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Expeditors International of Washington Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expeditors International of Washington and related companies with MarketBeat.com's FREE daily email newsletter.